Navidea Biopharmaceuticals Inc. is a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals. It announced the U.S. Food and Drug Administration (FDA) has accepted the Supplemental New Drug Application (sNDA) and granted a Priority Review for the expanded use of Lymphoseek (technetium 99m tilmanocept) Injection indicated for sentinel lymph node (SLN) detection in patients with head and neck cancer. Under the Prescription Drug User Fee Act (PDUFA), the FDA has set a June 16 target review date for the Lymphoseek sNDA.

Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of treatment, clinical research from New Zealand shows.

A new imaging technique for measuring blood flow in the heart and vessels can diagnose bicuspid aortic valve, and may lead to better prediction of complications. A Northwestern Medicine team reported the finding in the journal Circulation. In the study, the authors demonstrated for the first time a previously unknown relationship between heart valve abnormalities, blood flow changes in the heart and aortic disease. They showed that blood flow changes were driven by specific types of abnormal aortic valves, and they were able to directly associate blood flow patterns with aortic diseases.

The four MRI vendors fully ranked by KLAS are all within five points of each other as the MRI market becomes increasingly competitive. The newly released KLAS report MRI 2013: Sorting through the Noise examines what differentiates these vendors from one another, including their strengths and weaknesses.

ScImage announced availability of a Master Patient Index (MPI) Translator that provides healthcare professionals diagnostic imaging data residing in disparate systems, often located at unrelated facilities.